Medical Care

Global Immunocell Therapy Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Immunocell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunocell Therapy.
The Immunocell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immunocell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunocell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Segment by Type
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunocell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunocell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immunocell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunocell Therapy Market Perspective (2020-2031)
2.2 Global Immunocell Therapy Growth Trends by Region
2.2.1 Global Immunocell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immunocell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Immunocell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Immunocell Therapy Market Dynamics
2.3.1 Immunocell Therapy Industry Trends
2.3.2 Immunocell Therapy Market Drivers
2.3.3 Immunocell Therapy Market Challenges
2.3.4 Immunocell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunocell Therapy Players by Revenue
3.1.1 Global Top Immunocell Therapy Players by Revenue (2020-2025)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immunocell Therapy Revenue
3.4 Global Immunocell Therapy Market Concentration Ratio
3.4.1 Global Immunocell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunocell Therapy Revenue in 2024
3.5 Global Key Players of Immunocell Therapy Head office and Area Served
3.6 Global Key Players of Immunocell Therapy, Product and Application
3.7 Global Key Players of Immunocell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunocell Therapy Breakdown Data by Type
4.1 Global Immunocell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Immunocell Therapy Forecasted Market Size by Type (2026-2031)
5 Immunocell Therapy Breakdown Data by Application
5.1 Global Immunocell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Immunocell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immunocell Therapy Market Size (2020-2031)
6.2 North America Immunocell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immunocell Therapy Market Size by Country (2020-2025)
6.4 North America Immunocell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunocell Therapy Market Size (2020-2031)
7.2 Europe Immunocell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immunocell Therapy Market Size by Country (2020-2025)
7.4 Europe Immunocell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunocell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Immunocell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immunocell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Immunocell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunocell Therapy Market Size (2020-2031)
9.2 Latin America Immunocell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immunocell Therapy Market Size by Country (2020-2025)
9.4 Latin America Immunocell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunocell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Immunocell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immunocell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Immunocell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Immunocell Therapy Introduction
11.1.4 Novartis Revenue in Immunocell Therapy Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Immunocell Therapy Introduction
11.2.4 Gilead Sciences Revenue in Immunocell Therapy Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immunocell Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immunocell Therapy Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J Immunocell Therapy Introduction
11.4.4 J & J Revenue in Immunocell Therapy Business (2020-2025)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Immunocell Therapy Introduction
11.5.4 JW Therapeutics Revenue in Immunocell Therapy Business (2020-2025)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Immunocell Therapy Introduction
11.6.4 FOSUNKite Revenue in Immunocell Therapy Business (2020-2025)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Details
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Details
11.8.2 Autolus Therapeutics(Pipeline) Business Overview
11.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Introduction
11.8.4 Autolus Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.8.5 Autolus Therapeutics(Pipeline) Recent Development
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Details
11.9.2 Sorrento Therapeutics(Pipeline) Business Overview
11.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Introduction
11.9.4 Sorrento Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.9.5 Sorrento Therapeutics(Pipeline) Recent Development
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Details
11.10.2 Mustang Bio(Pipeline) Business Overview
11.10.3 Mustang Bio(Pipeline) Immunocell Therapy Introduction
11.10.4 Mustang Bio(Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.10.5 Mustang Bio(Pipeline) Recent Development
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Details
11.11.2 Bluebird Bio(Pipeline) Business Overview
11.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Introduction
11.11.4 Bluebird Bio(Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.11.5 Bluebird Bio(Pipeline) Recent Development
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Details
11.12.2 Cellectis(Pipeline) Business Overview
11.12.3 Cellectis(Pipeline) Immunocell Therapy Introduction
11.12.4 Cellectis(Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.12.5 Cellectis(Pipeline) Recent Development
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Details
11.13.2 Allogene Therapeutics(Pipeline) Business Overview
11.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Introduction
11.13.4 Allogene Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.13.5 Allogene Therapeutics(Pipeline) Recent Development
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Details
11.14.2 Celyad(Pipeline) Business Overview
11.14.3 Celyad(Pipeline) Immunocell Therapy Introduction
11.14.4 Celyad(Pipeline) Revenue in Immunocell Therapy Business (2020-2025)
11.14.5 Celyad(Pipeline) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immunocell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 3. Key Players of Natural Killer (NK) Cell Therapy
Table 4. Key Players of Others
Table 5. Global Immunocell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Immunocell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Immunocell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Immunocell Therapy Market Share by Region (2020-2025)
Table 9. Global Immunocell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Immunocell Therapy Market Share by Region (2026-2031)
Table 11. Immunocell Therapy Market Trends
Table 12. Immunocell Therapy Market Drivers
Table 13. Immunocell Therapy Market Challenges
Table 14. Immunocell Therapy Market Restraints
Table 15. Global Immunocell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Immunocell Therapy Market Share by Players (2020-2025)
Table 17. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2024)
Table 18. Ranking of Global Top Immunocell Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Immunocell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Immunocell Therapy, Headquarters and Area Served
Table 21. Global Key Players of Immunocell Therapy, Product and Application
Table 22. Global Key Players of Immunocell Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunocell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Immunocell Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Immunocell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Immunocell Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Immunocell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Immunocell Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Immunocell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Immunocell Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Immunocell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Immunocell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Immunocell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Immunocell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Immunocell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Immunocell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Immunocell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Immunocell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Immunocell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Immunocell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Immunocell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Immunocell Therapy Product
Table 50. Novartis Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Details
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Immunocell Therapy Product
Table 55. Gilead Sciences Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 56. Gilead Sciences Recent Development
Table 57. Bristol-Myers Squibb Company Details
Table 58. Bristol-Myers Squibb Business Overview
Table 59. Bristol-Myers Squibb Immunocell Therapy Product
Table 60. Bristol-Myers Squibb Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 61. Bristol-Myers Squibb Recent Development
Table 62. J & J Company Details
Table 63. J & J Business Overview
Table 64. J & J Immunocell Therapy Product
Table 65. J & J Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 66. J & J Recent Development
Table 67. JW Therapeutics Company Details
Table 68. JW Therapeutics Business Overview
Table 69. JW Therapeutics Immunocell Therapy Product
Table 70. JW Therapeutics Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 71. JW Therapeutics Recent Development
Table 72. FOSUNKite Company Details
Table 73. FOSUNKite Business Overview
Table 74. FOSUNKite Immunocell Therapy Product
Table 75. FOSUNKite Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 76. FOSUNKite Recent Development
Table 77. CARsgen Therapeutics (Pipeline) Company Details
Table 78. CARsgen Therapeutics (Pipeline) Business Overview
Table 79. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product
Table 80. CARsgen Therapeutics (Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 81. CARsgen Therapeutics (Pipeline) Recent Development
Table 82. Autolus Therapeutics(Pipeline) Company Details
Table 83. Autolus Therapeutics(Pipeline) Business Overview
Table 84. Autolus Therapeutics(Pipeline) Immunocell Therapy Product
Table 85. Autolus Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 86. Autolus Therapeutics(Pipeline) Recent Development
Table 87. Sorrento Therapeutics(Pipeline) Company Details
Table 88. Sorrento Therapeutics(Pipeline) Business Overview
Table 89. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product
Table 90. Sorrento Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 91. Sorrento Therapeutics(Pipeline) Recent Development
Table 92. Mustang Bio(Pipeline) Company Details
Table 93. Mustang Bio(Pipeline) Business Overview
Table 94. Mustang Bio(Pipeline) Immunocell Therapy Product
Table 95. Mustang Bio(Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 96. Mustang Bio(Pipeline) Recent Development
Table 97. Bluebird Bio(Pipeline) Company Details
Table 98. Bluebird Bio(Pipeline) Business Overview
Table 99. Bluebird Bio(Pipeline) Immunocell Therapy Product
Table 100. Bluebird Bio(Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 101. Bluebird Bio(Pipeline) Recent Development
Table 102. Cellectis(Pipeline) Company Details
Table 103. Cellectis(Pipeline) Business Overview
Table 104. Cellectis(Pipeline) Immunocell Therapy Product
Table 105. Cellectis(Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 106. Cellectis(Pipeline) Recent Development
Table 107. Allogene Therapeutics(Pipeline) Company Details
Table 108. Allogene Therapeutics(Pipeline) Business Overview
Table 109. Allogene Therapeutics(Pipeline) Immunocell Therapy Product
Table 110. Allogene Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 111. Allogene Therapeutics(Pipeline) Recent Development
Table 112. Celyad(Pipeline) Company Details
Table 113. Celyad(Pipeline) Business Overview
Table 114. Celyad(Pipeline) Immunocell Therapy Product
Table 115. Celyad(Pipeline) Revenue in Immunocell Therapy Business (2020-2025) & (US$ Million)
Table 116. Celyad(Pipeline) Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report


List of Figures
Figure 1. Immunocell Therapy Picture
Figure 2. Global Immunocell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immunocell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Chimeric Antigen Receptor (CAR) T Cell Therapy Features
Figure 5. Natural Killer (NK) Cell Therapy Features
Figure 6. Others Features
Figure 7. Global Immunocell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Immunocell Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Immunocell Therapy Report Years Considered
Figure 13. Global Immunocell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Immunocell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Immunocell Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Immunocell Therapy Market Share by Players in 2024
Figure 17. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Immunocell Therapy Revenue in 2024
Figure 19. North America Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Immunocell Therapy Market Share by Country (2020-2031)
Figure 21. United States Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Immunocell Therapy Market Share by Country (2020-2031)
Figure 25. Germany Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Immunocell Therapy Market Share by Region (2020-2031)
Figure 33. China Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Immunocell Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Immunocell Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Immunocell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 49. Gilead Sciences Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 51. J & J Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 52. JW Therapeutics Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 53. FOSUNKite Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 54. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 55. Autolus Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 56. Sorrento Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 57. Mustang Bio(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 58. Bluebird Bio(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 59. Cellectis(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 60. Allogene Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 61. Celyad(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies